Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-11

Clinical Trial Update: Influence of Δ9-tetrahydrocannabinol (THC) on Oxycodone Induced Ventilatory Depression in Healthy Volunteers [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the influence of THC on oxycodone-induced ventilatory depression in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxycodone (oxycodone)
  • THC (tetrahydrocannabinol)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Respiratory Depression, Cannabis Use | Phase 4 | Status: UNKNOWN